Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

1 envelope glycoprotein. In GeoVax's second generation vaccine, the DNA prime co-expresses GM-CSF with the virus-like particles, delivering a normal human protein that stimulates immune responses to the site of vaccination. All preventative Phase 1 human clinical trials conducted to date tested various combinations and doses of our DNA and MVA vaccines, their ability to raise anti-HIV humoral (antibody) and cellular (cytotoxic T cell) immune responses, as well as the vaccines' safety.

About HIV/AIDSAIDS is an epidemic that can affect anyone, regardless of race, gender, age or sexual orientation. 33 million people are currently infected globally and it is estimated that there will be 2.5 million new infections this year. Since the beginning of the epidemic, over a million people in the U.S. have contracted the virus. Every 9-1/2 minutes, someone in the U.S. is infected with AIDS. Globally, HIV is the top killer among women of reproductive age. HIV is a worldwide disease with different subtypes (or clades) of the virus predominating in different regions of the world. Clade B is the predominant subtype in North America. Globally, most infections involve subtypes AG, B, and C. GeoVax vaccines are currently designed to function against clade B.

For more information, please visit www.geovax.com.

Forward-Looking StatementsCertain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: HVTN will commence, complete enrollment, and generate data regarding GeoVax vaccine clinical trials as and when expected, GeoVax can develop and manufacture its vaccines with the desired characteristics
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Sept. 18, 2014  ADM Tronics Unlimited, Inc. ... Ph.D. to its corporate Advisory Board for business ... at the Harvard Medical School and Visiting Professor ... received his Masters degree in Electronics Engineering and ... University of Bologna. After spending a year as ...
(Date:9/18/2014)... 2014  A $3 million grant from The Glenn ... Michigan to establish a national center of excellence in ... Aging Research at U-M will focus on exploiting and ... effects of aging and postpone diseases in animal models. ... help develop medications that may help people live longer, ...
(Date:9/18/2014)...  Neurotrope, Inc. (OTCQB: NTRP) today announced the appointment ... the Company,s Board of Directors, effective September 12, 2014. ... the Board of seven members. Dr. Altstiel will also ... and a member of the Audit and Compensation Committees ... Scientific Advisory Board, a position he has held since ...
Breaking Medicine Technology:ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors 2Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors 3Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors 4
... The National Association of Boards of Pharmacy® ... PMP InterConnect is now fully operational, providing state prescription ... reducing prescription drug abuse and doctor shopping. NABP,s PMP ... facilitates the sharing of data between state PMPs, a ...
... RATON and JUPITER, Fla., Aug. 5, 2011 In ... Beach area, South Florida Radiation Oncology announced today that ... that enables a radically different approach to treating cancer ... Varian Medical Systems, was engineered from the ground up ...
Cached Medicine Technology:Interstate PMP Data Sharing through NABP PMP InterConnect Is Now a Reality 2Interstate PMP Data Sharing through NABP PMP InterConnect Is Now a Reality 3South Florida Radiation Oncology on the Forefront of Cancer Treatment with the TrueBeam™ Radiotherapy System from Varian Medical Systems 2South Florida Radiation Oncology on the Forefront of Cancer Treatment with the TrueBeam™ Radiotherapy System from Varian Medical Systems 3
(Date:9/19/2014)... Germany (PRWEB) September 19, 2014 ... that its new ND® Infusion Catheter is ... of Frankfurt. , The study commenced on September 4th, ... The use of the new catheter demonstrated a number ... known as stem cells. “We are at the forefront ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 In ... families find affordable home care options, Seniors Guide ... Agencies” on http://www.HomeCareChoice.com - their ... services in Virginia, North Carolina, Ohio, and Indiana. ... about licensing, costs, services offered, training and education, ...
(Date:9/19/2014)... 2014 One of the major trends ... material, making it useful in different application sectors such ... engineering. , Analysts forecast the Global Bioactive Material ... percent over the period 2013-2018. According to the report, ... drivers in the market. There will be an increased ...
(Date:9/19/2014)... CA (PRWEB) September 19, 2014 AttorneyOne.com, a ... the latest information from the FDA on Potassium Chloride ... Baxter International Inc. recalled one lot of Potassium ... on the shipping cartons. Potassium Chloride, administered intravenously, is used ... recall is based on a labeling error on the shipping ...
(Date:9/19/2014)... Yisrayl Hawkins, Pastor of The House of Yahweh wrote ... protect children. He begins by encouraging the reader not to ... there are many other children, like Michael Brown, who are ... than cancer all over the world and must be stopped ... billion Michaels in the world who were left to themselves ...
Breaking Medicine News(10 mins):Health News:First-in-man procedure utilizes a new method of stem cell delivery 2Health News:First-in-man procedure utilizes a new method of stem cell delivery 3Health News:Seniors Guide Offers Advice on How to Find the Right Home Health Care Agency 2Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 2Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 3Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 4Health News:Baxter Recalls Potassium Chloride Injection: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Yisrayl Hawkins Says the Michael Brown Scenario Will Continue Without Swift Action in New Post 2
... ... (HLA), the nation,s first interactive health literacy software tool, today announced the 1st Annual ... , ... 7, 2010 -- Health Literacy Innovations (HLI), creators of the Health Literacy ...
... ... View" hits radio on July 6th. , ... Atlanta, GA (PRWEB) July 7, 2010 -- Sponsored by ... Southeast this summer for Ryan Hamner Presents: “Hear the Heart” Summer Tour 2010. ...
... ... and request a free 15-page translation localization report that details areas of improvement. ... Westborough, MA (PRWEB) ... its Localization Quiz at http://www.globalvis.com/freebies/localization-quiz/ . , , , , ,Visitors ...
... 2010 Approximately 10% of low back pain (LBP) ... study published in the August issue of Pain ... of health literacy in patients with chronic lower back ... a person,s disability more than pain intensity or a ...
... Obesity ... creator of the Zone Diet. , ... Boston (Vocus) July 6, 2010 -- Appearing on The Mel Robbins Show , ... bestselling author of The Zone, detailed the underlying causes of America’s obesity crisis and talked ...
... Jackson Surgical Assistants ... experience, has joined the executive team as Medical Director. , ... Alpharetta, GA (July 6, 2010) – Jackson Surgical Assistants (JSA) ... has joined the executive team as Medical Director. Dr. Funk will be responsible for ...
Cached Medicine News:Health News:Health Literacy Innovations Announces 1st Annual Health Literacy Innovator Award — Anonymous Donor Offers Prize Money To Winners 2Health News:Health Literacy Innovations Announces 1st Annual Health Literacy Innovator Award — Anonymous Donor Offers Prize Money To Winners 3Health News:Ryan Hamner's Free Hear The Heart Tour Sweeping The South Four-Time Cancer Survivor, Sings Hope To Others 2Health News:Test your Localization Abilities on globalvis.com 2Health News:Attitudes, beliefs and health literacy impact how patients manage chronic lower-back pain 2Health News:Attitudes, beliefs and health literacy impact how patients manage chronic lower-back pain 3Health News:Attitudes, beliefs and health literacy impact how patients manage chronic lower-back pain 4Health News:Zone Diet Creator Dr. Sears Discusses Obesity Causes and Solutions on Mel Robbins Radio Show 2Health News:Jackson Surgical Assistants Names Dr. Sidney Funk as Medical Director 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: